Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
Nature Medicine2004Vol. 10(9), pp. 935–941
Citations Over TimeTop 10% of 2004 papers
Stéphane Temmerman, Kévin Pethe, Marcela Parra, Sylvie Alonso, Carine Rouanet, Thames Pickett, Annie Drowart, Anne‐Sophie Debrie, Giovanni Delogu, Franco D. Menozzi, Christian Sergheraert, Michael J. Brennan, Françoise Mascart, Camille Locht
Related Papers
- → Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials(2013)257 cited
- → Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis –infected Individuals(2009)122 cited
- → Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis(2005)66 cited
- → The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy(2022)15 cited
- → Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals(2009)7 cited